Ginkgo biloba and related compounds in Alzheimer's disease

Psychiatric Annals

Volumn 32, Issue 1, 2002, Pages 13-18

  Sommer, Barbara R ^a   Schatzberg, Alan F ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; DONEPEZIL; GALANTAMINE; GINKGO BILOBA EXTRACT; GINKGOLIDE B; MUSCARINIC RECEPTOR; NEUROTRANSMITTER; QUINUCLIDINYL BENZILATE; RIVASTIGMINE; SCAVENGER; TACRINE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; WARFARIN;

ALZHEIMER DISEASE; BLEEDING; BLOOD VESSEL PERMEABILITY; BRAIN DYSFUNCTION; CAPILLARY RESISTANCE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; DIET SUPPLEMENTATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG BINDING; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DRUG SYNTHESIS; DRUG TOLERABILITY; FRUIT; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; META ANALYSIS; MULTIINFARCT DEMENTIA; NEUROTRANSMISSION; NONHUMAN; NUT; PATHOPHYSIOLOGY; PLANT LEAF; RANDOMIZED CONTROLLED TRIAL; RASH; REVIEW; SIDE EFFECT; STATISTICAL ANALYSIS; SUBDURAL HEMATOMA; SYNAPSE; THROMBOCYTE;

EID: 0242319831     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-20020101-05     Document Type: Review

References (32)

1. Curtis-Prior P, Vere D, Fray P. Therapeutic value of ginkgo biloba in reducing symptoms of decline in mental function. J Pharm Pharmacol. 1999;51:535-541.
2. Fugh-Berman A, Cott JM. Dietary supplements and natural products as psychotherapeutic agents. Psychosom Med. 1999;61:712-728.
3. DeFeudis FV. Ginkgo Biloba Extract (EGb 761): Pharmacological Activities and Clinical Applications. Paris: Editions Scientifiques Elsevier; 1991:3-6, 10-13.
4. Itil T, Martorano D. Natural substances in psychiatry (ginkgo biloba in dementia). Psychopharmacology Bulletin. 1995;31:147-158.
5. Oken BS, Storzbach DM, Kaye JA. The efficacy of ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol. 1998;55:1409-1415.
6. Smith MA, Perry G, Richey PL, et al. Oxidative damage in Alzheimer's. Nature. 1996;382:120-121. Letter.
7. Chung KF, Dent G, McCusker M, Guinot PH, Page CP, Barnes PJ. Effect of a ginkgolide mixture (BN 52053) in antagonising skin and platelet responses to platelet activating factor in man. Lancet. 1987;1:248-251.
8. McGeer PL, Schulzer M, McGeer EG. Arthritis and antiinflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology. 1996;47:425-432.
9. Koltai M, Hosford D, Guinot P, Esanu A, Braquet P. Platelet activating factor (PAF): a review of its effects, antagonists and possible future clinical implications (Part I). Drugs. 1991;42:9-29.
10. Aisen PS, Davis KL. Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Am J Psychiatry. 1994;151:1105-1113.
11. Brietner JC, Gau BA, Welsh KA, et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology. 1994;44:227-232.
12. Davies P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet. 1976;2:1403. Letter.
13. Taylor JE. Neuromediator binding to receptors in the rat brain: the effect of chronic administration of ginkgo biloba extract. Presse Med. 1986;15:1491-1493.
14. Subhan Z, Hindmarch I. The psychopharmacological effects of ginkgo biloba extract in normal healthy volunteers. Int J Clin Pharmacol Res. 1984;4:89-93.
15. Kleijnen J, Knipschild P. Ginkgo biloba for cerebral insufficiency. Br J Clin Pharmacol. 1992;34:352-358.
16. Warburton DM. Clinical psychopharmacology of ginkgo biloba extract. Presse Med. 1986;15:1595-1604.
17. Rösler M, Retz W, Thome J, Riederer P. Free radicals in Alzheimer's dementia: currently available therapeutic strategies. J Neural Transm Suppl. 1998;54:211-219.
18. Vesper J, Hansgen KD. Efficacy of ginkgo biloba in 90 out-patients with cerebral insufficiency caused by old age: results of a placebo-controlled, double-blind trial. Phytomedicine. 1994;1:9-16.
19. Hofferberth B. The efficacy of EGb 761 in patients with senile dementia of the Alzheimer type, a double-blind, placebo-controlled study on different levels of investigation. Human Psychopharmacology. 1994;9:215-222.
20. Haase J, Halama P, Horr R. Effectiveness of brief infusions with Ginkgo biloba Special Extract EGb 761 in dementia of the vascular and Alzheimer type. Z Gerontol Geriatr. 1996;29:302-309.
21. Kanowski S, Herrmann WM, Stephan K, Wierich W, Horr R. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry. 1996;29:47-56.
22. Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF. A placebo-controlled, double-blind randomized trial of an extract of ginkgo biloba for dementia. JAMA. 1997;278:1327-1332.
23. Maurer K, Ihl R, Dierks T, Frolich L. Clinical efficacy of ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type. J Psychiatr Res. 1997;31:645-655.
24. Le Bars PL, Kieser M, Itil KZ. A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia. Dement Geriatr Cogn Disord. 2000;11:230-237.
25. van Dongen MC, van Rossum E, Kessels AG, Sielhorst HJ, Knipschild PG. The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial. J Am Geriatr Soc. 2000;48:1183-1194.
26. Schwartz GE. Development and validation of the Geriatric Evaluation by Relative's Rating Instrument (GERRI). Psychology Reports. 1983;53:479-488.
27. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry. 1984;141:1356-1364.
28. Skogh M. Extracts of ginkgo biloba and bleeding or haemorrhage. Lancet. 1998;352:1145-1146. Letter.
29. Matthews MK Jr. Association of ginkgo biloba with intra-cerebral hemorrhage. Neurology. 1998;50:1933-1934. Letter.
30. Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of ginkgo biloba extract. N Engl J Med. 1997;336:1108. Letter.
31. Rowin J, Lewis S. Spontaneous bilateral subdural hematomas associated with chronic ginkgo biloba ingestion. Neurology. 1996;46:1775-1776.
32. Corrigan JJ Jr. Coagulation problems relating to vitamin E. American Journal of Pediatric Hematology/Oncology. 1979;1:169-173.